🔎 Trials Near Me

Utama › Penyakit Hati Steatotik › Florida › Miami

Kajian klinikal Penyakit Hati Steatotik di Miami, FL

16 kajian untuk Penyakit Hati Steatotik sedang mencari peserta di lokasi dalam dan sekitar Miami (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Mengambil pesertaFasa 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Mengambil pesertaFasa 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07701993

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Mengambil pesertaFasa 2
  • Evolution Clinical Trials, Miami
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07527910

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Mengambil pesertaFasa 2
  • University of Miami Health System, Miami
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05832229

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Mengambil pesertaFasa 2
  • Genoma Research Group, Inc., Miami
  • Med Research of Florida, LLC, Miami
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Mengambil pesertaFasa 3
  • Evolution Clinical Trials, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Mengambil pesertaFasa 3
  • Akero Clinical Study Site, Miami
  • Akero Clinical Study Site, Miami
Umur 18 hingga 80 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Mengambil pesertaFasa 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • dan 3 lagi
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07221188

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Mengambil pesertaFasa 3
  • 89bio Clinical Study Site, Miami
Umur 18 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Mengambil pesertaFasa 3
  • 89bio Clinical Study Site, Miami
  • 89bio Clinical Study Site, Miami
  • 89bio Clinical Study Site, Miami
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06419374

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Mengambil pesertaFasa 2
  • GSK Investigational Site, Miami
Umur 18 hingga 70 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Mengambil pesertaFasa 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • dan 4 lagi
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Jul 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Mengambil pesertaFasa 2
  • GSK Investigational Site, Miami
Umur 18 hingga 75 · Semua jantina · Dikemas kini 8 Jul 2026 · NCT06920043

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
  • Genoma Research Group, Inc, Miami
  • Med Research of Florida, LLC, Miami
Umur 18 hingga 75 · Semua jantina · Dikemas kini 16 Apr 2026 · NCT05648214

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Mengambil pesertaKajian pemerhatian
  • Clinical Pharmacology of Miami, Miami
Umur 18 hingga 75 · Semua jantina · Dikemas kini 14 Ogo 2025 · NCT07122700

Kajian Penyakit Hati Steatotik di bandar lain

Kajian lain di Miami

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.